Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400
Closed -$29.8K 4649
2025
Q4
$29.8K Sell
400
-2,600
-87% -$190K ﹤0.01% 4195
2025
Q3
$202K Sell
3,000
-300
-9% -$19.9K ﹤0.01% 3313
2025
Q2
$215K Buy
+3,300
New +$198K ﹤0.01% 3309
2024
Q4
Sell
-27,700
Closed -$2.26M 5136
2024
Q3
$2.26M Buy
27,700
+1,200
+5% +$96K ﹤0.01% 1828
2024
Q2
$1.97M Buy
26,500
+11,600
+78% +$870K ﹤0.01% 2118
2024
Q1
$1.16M Buy
14,900
+6,000
+67% +$446K ﹤0.01% 2442
2023
Q4
$636K Buy
8,900
+3,000
+51% +$209K ﹤0.01% 2752
2023
Q3
$409K Buy
5,900
+3,300
+127% +$249K ﹤0.01% 2965
2023
Q2
$211K Buy
2,600
+2,100
+420% +$172K ﹤0.01% 3049
2023
Q1
$40.4K Buy
+500
New +$40.3K ﹤0.01% 3254

Other funds holding HOLX

Walleye Capital's HOLX Position: Q1 2026 in Review

Walleye Capital sold out of Hologic (HOLX) in Q1 2026, closing a stake of 20,002 shares — an estimated $1.49M sold.

Walleye Capital first reported a position in HOLX in Q4 2019 and held it in 14 quarters. The position peaked at $2.57M in Q4 2024. 703 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Walleye Capital reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 20,002 Hologic shares in Q1 2026, an estimated $1.49M.
  • Walleye Capital first reported a position in Hologic in Q4 2019 and held it in 14 quarters.
  • Walleye Capital's Hologic position peaked at $2.57M in Q4 2024.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.